Market Place
Sourcing Support
Osivax Vaccinates First Participant in OVX836 Booster Trial
14 Nov 2024 //
BUSINESSWIRE
Osivax-KM Biologics License For Universal Flu Vaccine In Japan
10 Sep 2024 //
BUSINESSWIRE
Osivax completes enrollment for Phase 1 trial of OVX033
25 Jun 2024 //
BUSINESSWIRE
Osivax Announces Vaccination of Last Patient in Ph 2a Trial Evaluating OVX836
26 Mar 2024 //
BUSINESSWIRE
Osivax Announces Vaccination of First Participant in Trial Evaluating OVX033
15 Feb 2024 //
BUSINESSWIRE
Osivax Appoints Dr. Nicola Groth as Chief Medical Officer
25 Jan 2024 //
BUSINESSWIRE
Osivax Receives USD 1.5M Grant from NIAID to Advance Development of OVX836
05 Dec 2023 //
BUSINESSWIRE
Osivax Announces Publicationof Ph 2a Data for OVX836
27 Jul 2023 //
BUSINESSWIRE
Osivax Publishes Data for Sarbecovirus Vaccine Candidate, OVX033
06 Jul 2023 //
BUSINESSWIRE
Osivax Announces Vaccination of Participant in Phase 2a Trial Evaluating OVX836
15 Jun 2023 //
BUSINESSWIRE
Osivax Awarded Grant from a Leading Non-Governmental Organization for OVX836
28 Mar 2023 //
BUSINESSWIRE
Osivax Appoints Dr. Chris Martin to its Board of Directors
23 Feb 2023 //
BUSINESSWIRE
Osivax Announces Last Patient Last Visit in Two Phase 2a Clinical Trials
21 Dec 2022 //
BUSINESSWIRE
Osivax Appoints Vincent Bille as CMO & shows Manufacturing Progress for OVX836
12 Oct 2022 //
BUSINESSWIRE
Osivax Announces Vaccine Data Presentations at Global Influenza Conferences
01 Sep 2022 //
BUSINESSWIRE
Osivax Secures EUR 10M Grant from Bpifrance to Support Development of OVX836
23 Jun 2022 //
BUSINESSWIRE
Osivax Provides Development Update on Lead Influenza Vaccine Candidate OVX836
25 May 2022 //
BUSINESSWIRE
Osivax Collaborates with the NIAID for Broad-Spectrum Influenza Vaccines
17 May 2022 //
BUSINESSWIRE
Osivax Appoints Dr. Michael Watson to Its Board of Directors
14 Apr 2022 //
BUSINESSWIRE
French biotech Osivax nabs funding boost for universal flu, covid vaccine work
09 Jul 2020 //
FIERCE BIOTECH
Osivax Receives Over EUR 30M in Public Funding to Support Development
07 Jul 2020 //
BUSINESSWIRE
Osivax Enters Agreement with U.S. NIH to Test Universal Flu Vaccine Candidate
05 Dec 2019 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.